Cannara Biotech Inc. (TSXV: LOVE)
Canada
· Delayed Price · Currency is CAD 0.750
-0.050 (-6.25%)
Dec 20, 2024, 2:54 PM EST
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 67.51 million as of December 20, 2024. Its market cap has decreased by -18.55% in one year.
Market Cap
67.51M
Enterprise Value
109.22M
Revenue
81.75M
Ranking
n/a
PE Ratio
10.71
Stock Price
0.75
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 67.51M, a decrease of -68.10%. That is a compound annual growth rate of -17.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 67.51M | -9.64% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | 59.03M | -33.19% |
| Dec 31, 2019 | 88.35M | -58.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bausch + Lomb Corporation | 9.20B |
| Bausch Health Companies Inc. | 3.87B |
| WELL Health Technologies Corp. | 1.74B |
| Curaleaf Holdings, Inc. | 1.65B |
| dentalcorp Holdings Ltd. | 1.60B |
| Tilray Brands, Inc. | 1.50B |
| Sienna Senior Living Inc. | 1.30B |
| Cronos Group Inc. | 1.04B |